|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 10075310.2 (espacenet) (Federated) (European Patent Register), 20050909 | | Patent/reg. no. and date | DK/EP 2236155, 20120516 | | Publication date | 20101006 | | Priority no. and date | EP 04255471, 20040909 | | EP pub. no. and date |
EP 2236155 20101006 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
CH-4056 Basel, CH | | Applicant ref. no. | NGC/AP/144351 | | Inventor | Gregersen, Jens Peter, Novartis Vaccines and Diagnostics GmbH
Emil-von-Behring Strasse 76
35041 Marburg, DE | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/145 (2006.01) , C12Q 1/70 (2006.01) | | Title | Nedbringelse af potentielle iatrogene risici i forbindelse med influenzavacciner | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
